The Checkpoint Kinase 1 Inhibitor Prexasertib Induces Regression of Preclinical Models of Human Neuroblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Checkpoint Kinase 1 Inhibitor Prexasertib Induces Regression of Preclinical Models of Human Neuroblastoma

Published:2017-03-07 Issue:15 Volume:23 Page:4354-4363
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Lowery Caitlin D.,VanWye Alle B.,Dowless Michele,Blosser Wayne,Falcon Beverly L.,Stewart Julie,Stephens Jennifer,Beckmann Richard P.,Bence Lin Aimee,Stancato Louis F.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Targeting of DNA Repair Pathways in Pediatric Extracranial Solid Tumors: Current State and Implications for Immunotherapy;Cancers;2024-04-25

2. A new wave of innovations within the DNA damage response;Signal Transduction and Targeted Therapy;2023-09-08

3. Identification of hub genes and their correlation with infiltration of immune cells in MYCN positive neuroblastoma based on WGCNA and LASSO algorithm;Frontiers in Immunology;2022-10-12

4. DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities;Experimental & Molecular Medicine;2022-10-07

5. Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma;Frontiers in Oncology;2022-09-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP